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Abstract
Objective: to study the changes in t cell subsets and
Il-7  in  HIV-1-infected  patients  after  seven  years  of
highly active antiretroviral therapy (HaaRt). 
Methods: Seventy-five individuals were included in this
study (25 with effective HaaRt, 18 with ineffective
HaaRt, 17 untreated HIV+ patients, and 15 volun-
teers in the HIV negative control group). the counts
of Cd4+, Cd8+, Cd8/Cd38+, and Cd8/HladR+ t
cells as well as the Il-7 protein expression was mea-
sured at 5 time points during a period of seven years
in patients starting HaaRt (baseline) and in the HIV
negative control group. the expression of Cd127 on
Cd3+ t cells was measured by flow cytometry at a sin-
gle time point (after 7 years) in patients with HaaRt
and was compared with untreated HIV+ patients and
the HIV negative control group. 
Results: at baseline Cd4+ t cell counts of HIV-1-in-
fected  patients  were  lower  than  that  in  the  control
group (p < 0.01), whereas the Cd8+, Cd8/HladR+
and Cd8/Cd38+ t cell counts were higher than those
in the control group (p < 0.01). after seven years of
effective  HaaRt,  the  Cd4+ t  cell  counts  had  in-
creased and the Cd8+ t cell count had decreased, al-
though not to the normal levels (p < 0.05). both the
Cd8/HladR+ and Cd8/Cd38+ t cell counts had
gradually approached those of the control group (p >
0.05).  In  the  ineffective  HaaRt  group,  the
Cd8/Cd38+ t cell count had not decreased signifi-
cantly, and Cd8/HladR+ t cell count gradually de-
creased.  before  treatment,  Il-7  serum  levels  of  pa-
tients were significantly higher than that in the control
group  (p <  0.01).  after  seven  years  of  effective
HaaRt, Il-7 levels had gradually decreased, but were
still higher than in the control group (p < 0.01). the
Cd127 expression on Cd3+ Cd8+ t cells in effective
HaaRt patients was higher than in untreated HIV+
patients (p < 0.05), but was lower than that in the con-
trol  group  (p <  0.05).  Cd127  expression  on  Cd3+
Cd4+ t cells was not significantly different among the
control group, untreated HIV+ patients and effective
HaaRt group.  
Conclusion: after seven years of effective HaaRt, the
quantity  and  capacity  of  t  cell  subsets  and  Il-7  in
HIV-1-infected  patients  had  been  partially  restored,
and the abnormal immune activation has significantly
diminished.
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IntRoduCtIon
Human immunodeficiency virus-1 (HIV-1) mainly at-
tacks Cd4+ t cells of the immune system, which leads
to  a  serious  impairment  of  immune  function.  the
pathological changes associated with HIV-1 infection
include changes in both the population and function
of Cd4+ t cells, as well as abnormal activation of the
immune system [1]. Highly active antiretroviral therapy
(HaaRt)  can  inhibit  virus  replication  in  vivo,  and
thereby  inhibit  the  progression  of  aIdS  [2].  It  has
been reported that HaaRt can partially restore im-
mune  function  in  HIV-1-infected  patients;  however,
how long the recovery period is and how long the in-
hibition of abnormal immune activation would last re-
main unknown. Moreover, there is still a lack of stud-
ies on the function of long-term HaaRt on immune
restauration in HIV-1-infected patients. 
Il-7, which plays a crucial role in t cell homeosta-
sis, also regulates peripheral naive t cell survival and
rhIl-7  was  found  to  simultaneously  increase  Cd4+
and Cd8+ t cell counts, particularly memory t cells.
furthermore,  the  expression  level  and  regulatory
mechanism of the Il-7Rʱ chain (Cd127) is positively
correlated  with  the  lifetime  of  t  cells  in  peripheral
blood. the expression of Cd127, which is a specific
surface marker of t cells, can be lowered by HIV-1-
specific lymphocytes, thereby impairing its regulatory
function. low Cd127 levels on Cd8+ t cells lead to a
proliferation of HIV (see also discussion).
In this study, the changes in t lymphocyte subsets
and peripheral blood Il-7 protein expression was in-
vestigated during a period of seven years in patients
starting  HaaRt  (baseline)  and  in  the  HIV  negative
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on Cd3+ t cells were measured by flow cytometry in
patients with HaaRt and was compared with untreat-
ed HIV+ patients and the HIV negative control group.
by  analysing  differences  among  those  groups,  we
aimed to investigate the immune restauration achieved
by seven years of HaaRt in HIV-1-infected patients. 
MatERIalS and MEtHodS
Study GRouPS
the  HIV-1-infected  adults  were  retrospectively  re-
viewed between 1998 and 2009 at the St. Josef Hospi-
tal,  Ruhr-university  bochum,  Germany  and  Qing
Chun Hospital, Zhejiang Province, China. all the pa-
tients infected by HIV-1 had no severe opportunistic
infections. Patients receiving more than seven years of
HaaRt  were  divided  into  two  groups:  Effective
group  (group  a):  plasma  HIV-Rna  lower  than  the
level  of  detection  (50  copies/ml)  after  1  year  of
HaaRt.  Ineffective  group  (group  b):  plasma  HIV-
Rna  higher  than  the  level  of  detection  (50
copies/ml) after 1 year of HaaRt. the cause of in-
effective  therapy  (e.g.  resistance  or  lack  of  compli-
ance) was not investigated. the plasma HIV-Rna lev-
el  of  the  patients  was  documented  annually.  If  the
plasma HIV-Rna level was repeatedly above detection
level  antretroviral  therapy  was  changed  within  one
year, but was still not stable after 7 years. Some analy-
ses were compared with an untreated group (group C):
HIV-1  infected  individuals  who  didn’t  receive  anti-
retroviral therapy. as a control group served HIV neg-
ative volunteers with no history of acute or chronic ill-
nesses, especially immunologic diseases and tumours,
no infections during the previous two months and no
abnormal findings in physical examinations.
SaMPlE CollECtIon and PRoCESSInG
Peripheral  blood  (7  ml)  was  taken  from  each  of 
the subjects, and the samples were drawn into tubes
with  Edta.  Half  of  the  sample  was  measured 
by flow cytometry (becton, dickinson and Company).
Plasma  extracted  from  the  other  half  of  the 
sample  was  used  to  measure  the  viral  load  and 
Il-7  protein  expression.  the  blood  samples  of  the
patients who received long-term HaaRt were taken
annually.  
dEtECtIon of PlaSMa HIV-Rna
an  HIV-1  Monitor  1.5  commercial  kit  (Roche)  and
CobaS ampliSensor-PCR were used for quantitative
analysis  of  HIV-Rna  in  the  plasma  samples.  the
measurements were performed according to the manu  -
facturers’ instructions.  
floW CytoMEtRy
three different combinations of fluorescent antibod-
ies  (Cd8+ Cd127+ t,  Cd8+ Cd45Ro+ Cd127+
t and Cd8+ Cd45Ra+ Cd127+ t) were separately
drawn  into  three  tubes  of  50  ﾵl  Edta  blood 
from each sample. flow cytometry (becton, dickinson
and  Company)  and  System  u  software  were  used 
to ana  lyse the results. the same method was applied 
to  detect  Cd4+,  Cd8+,  Cd8/Cd38+,  and  Cd8/
HladR+ t  cells  in  the  peripheral  blood.  the 
fluorescent  antibodies  used  were  as  follows:  Cd3
fItC,  Cd4  PerCP  5.5,  Cd8  aPC-H7, 
Cd45Ro PECy7, Cd45Ra PECy7, Cd127 PE, Cd4
fItC,  Cd8  fItC,  Cd38  PE,  and  anti-Hla-dR 
aPC.
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Table 1. baseline characteristics of study population.
Effective Group Ineffective Group untreated Group Control Group
number of Subjects 25 18 17 15
Sex
Male 19(76%) 13(72.2%) 13(76.5%) 9(60%)
female 6(24%) 5(27.8%) 4(23.5%) 6(40%)
age 47.6ﾱ9.1 45.7ﾱ10.4 39.7ﾱ11.3 40.5ﾱ9.7
(35～71) (31～60) (36～63) (33～57)
transmission
Sexual 21(84%) 16(88.8%) 16(94.1%) —
blood 3(12%) 1(5.6%) 1(5.9%) —
other 1(4%) 1(5.6%) 0—
Cd4+ t (cells/ʼl) * 187 175 341 736
(22~367) (56~341) (78~400) (452~1038)
＜200 13(52%) 10(55.6%) 2(11.8%) 0
≥200~＜350 11(44%) 8(44.4%) 5(29.4%) 0
≥350 1(4%) 0 10(58.8%) 15(100%)
therapy
2nRtIs+nnRtI 13(52%) 11(61.1%) ——
2nRtIs+PI 12(48%) 7(38.9%) ——
*: baseline Cd4+ t  cell counts are shown by medians with ranges. nRtI: nucleoside Reverse transcriptase Inhibitor, nnR-
tI: non-nucleoside Reverse transcriptase Inhibitor, PI: Protease Inhibitor.
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ElISa was used to determine the concentration of Il-
7 (ﾵg/l). the absorbance at 450 nm was measured us-
ing an ElISa Reader. the reagent was purchased from
R  &  d  Company,  uS.  the  measurements  were  per-
formed according to the manufacturer’s instructions.  
StatIStICal analySIS
all data was denoted by mean and standard deviation
(x – ﾱ Sd). to compare the t cell subsets during the
long-term effective HaaRt, matching Student’s t-test
was used. Mann-Whitney u-test was used for analysis
of the other continuous data. all data were entered and
analyzed using SPSS version 16 packages, and p value
of less than 0.05 was considered statistically significant.
RESultS
tHE ClInICal CHaRaCtERIStICS of tHE Study
PoPulatIon
according to the included criteria, seventy-five individ-
uals were enrolled in this study. of the seventy-five in-
dividuals, sixty were HIV-1-infected patients (25 with
effective HaaRt, 18 with ineffective HaaRt, 17 un-
treated HIV+ patients), and fifteen were HIV negative
volunteers (control group). the viral loads of effective
HaaRt therapy patients were lower than the level of
detection (50 copies/ml), and the viral loads of inef-
fective HaaRt therapy patients fluctuated between 56
copies/ml  to  185000  copies/ml  (data  not  shown).
futher epidemiological and clinical baseline character-
istics of the 4 different groups are shown in table 1.
CHanGES In Cd4+ and Cd8+ t CEllS aftER SEVEn
yEaRS of EffECtIVE HaaRt 
before treatment, the Cd4+ t cell counts of  group a
patients were significantly lower than that in the con-
trol group (201 vs 751 cells/ﾵl, p < 0.01) as shown in
figure  1.  after  seven  years  of  effective  HaaRt,
Cd4+ t cell counts had increased significantly (652 vs
201 cells/ﾵl, p <0.05). However, although the counts
had reached a stable level after the third year of the
treatment,  it  was  still  less  than  that  in  the  control
group after seven years effective HaaRt (652 vs 751
cells/ﾵl, p < 0.05). the mean Cd4+ t recovery in pa-
EuRoPEan JouRnal of MEdICal RESEaRCH november 10, 2011 475
Fig. 1. Changes of Cd4+ t and Cd8+ t cells
during a period of seven years effective HaaRt
(group a) (x – ﾱ Sd, n=25). *: P<0.05 compared
with  Control,  **:  P<0.05  compared  with
Pretherapy.
Fig.  2.  Changes  of  Cd8/Cd38+  t  and
Cd8/HladR+ t cell during a period of seven
years  effective  HaaRt  (x – ﾱ  Sd,  n=25).  *:
P<0.05 compared with Control, **: P<0.05 com-
pare with Pretherapy. Reference level of Cd8/
Cd38+  t:  90-600  cells/ﾵl,  Reference  level  of
Cd8/ HladR+ t: 30-200 cells/ﾵl.
1) Shou###_Umbruchvorlage  12.10.11  12:51  Seite 475tients with 200-350/ﾵl Cd4+ t at baseline was higher
than in patients starting with less than 200/ﾵl Cd4+
t. after 1, 3, 5 and 7 years of treatment the mean
Cd4+ t cell count in the 200-350/ﾵl group increased
to 605/ﾵl, 775/ﾵl, 801/ﾵl and 838/ﾵl respectively.
In the same time frame the mean Cd4+ t cell count in
the  <200/ﾵl  group  increased  to  328/ﾵl,  476/ﾵl,
485/ﾵl and 498/ﾵl respectively (table 2).
In  addition,  before  treatment,  the  Cd8+ t  cell
counts in the above patients were significantly higher
than that in the control group (1255 vs 593 cells/ﾵl, 
p <  0.01).  after  seven  years  of  effective  HaaRt, 
the  Cd8+ t  cell  counts  had  decreased  significantly,
but  were  still  higher  than  that  in  the  control  group
(911 vs 593 cells/ﾵl, p < 0.05) (fig. 1).
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Fig. 3. Changes of Cd8/Cd38+ t cells during a
period  of  seven  years  HaaRt  (x – ﾱ  Sd,/ﾵl).
Patient numbers: Effective group (a) (n = 25),
Ineffective group (b) (n = 18).
Fig. 4. Changes of Cd8/HladR+ t cells during
a period of seven years HaaRt (x – ﾱ Sd,/ﾵl).
Patient numbers: Effective group (a) (n = 25),
Ineffective group (b) (n = 18).
fig.  5.  Changes  of  Il-7  serum  concentration
during a period of seven years effective HaaRt
(group a) (x – ﾱ Sd, n=25). *: P<0.05 compared
with Control.
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CEllS aftER SEVEn yEaRS HaaRt
before  therapy,  both  the  Cd8/Cd38+ t  cell  count
and the Cd8/HladR+ t cell count of  group a pa-
tients were found to be significantly higher than in the
control  group  (1048  vs  314  cells/ﾵl,  703  vs  125
cells/ﾵl,  p <  0.01).  after  seven  years  of  effective
HaaRt,  both  Cd8/Cd38+ and  Cd8/HladR+ t
cell counts had returned close to normal levels (394 vs
314 cells/ﾵl, 90 vs 125 cells/ﾵl, p > 0.05) as shown
in figure 2. 
furthermore, the Cd8/Cd38+ t cell counts in the
ineffective HaaRt group (b) did not decrease signifi-
cantly (fig. 3), and were higher than that of the con-
trol group after seven years of HaaRt (1079 vs 324
cells/ﾵl,  p <0.05).  However,  Cd8/HladR+ t  cell
counts of the ineffective HaaRt group gradually de-
creased (fig. 4).
analySIS of Il-7 PRotEIn ExPRESSIon aftER SEVEn
yEaRS of EffECtIVE HaaRt 
before treatment, the peripheral blood Il-7 levels in
HIV-1-infected patients were significantly higher than
in controls (29.5 vs 7.1 pg/ml, p < 0.01). over the
seven years of effective HaaRt, there was a gradual
decrease in the levels of Il-7 (fig. 5). In the first year
of  HaaRt,  the  Il-7  level  showed  the  largest  de-
crease; however, by the seventh year of HaaRt, the
Il-7  level  was  still  higher  than  that  in  the  controls
(11.2 vs 7.1 pg/ml, p < 0.05). 
CHanGES In Cd127 ExPRESSIon on Cd3+ t CEllS
aftER SEVEn yEaRS of EffECtIVE HaaRt
Cd127 expression on the surface of Cd3+ Cd8+ t
cells  in  untreated  HIV-1-infected  patients  (group  C)
was lower than in the control group (43.5% vs 82.3%,
p < 0.05). the Cd127 expression in group a patients
with effective HaaRt was higher than that in group
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Fig. 6. difference of Cd127 expression
on Cd3+ Cd8+ t cell subsets in group
a (x – ﾱ Sd, %). Patient numbers: Con-
trol group (n = 15), untreated group (n
= 17), Effective HaaRt group (a) (n =
25).  *:  P<0.05  compared  with  Control,
**:  P<0.05  compared  with  untreated
HIV+ patients.
Fig. 7. difference of Cd127 expression
on Cd3+ Cd4+ t cell subsets in group
a (x – ﾱ Sd, %). Patient numbers: Con-
trol group (n = 15), untreated group (n
= 17), Effective HaaRt group (a) (n =
25).
Table  2. the  mean  Cd4+ t  cell  count  (cells/ﾵl)  during
HaaRt.
baseline Cd4  1 year 3 years 5 years 7 years
(cells/ﾵl)
<200 328 476 485 498
200~350 605 775 801 838
1) Shou###_Umbruchvorlage  12.10.11  12:51  Seite 477C (59.4% vs 43.5%, p < 0.05), but still lower than that
in the control group (59.4% vs 82.3%, p < 0.05). after
seven years in group a, the expression level of Cd127
on the surface of virgin (Cd45Ra+) Cd3+ Cd8+ t
cells had returned close to that in the control group
(83.8% vs 85.5%, p > 0.05). although Cd127 expres-
sion on memory (Cd45Ro+) Cd3+ Cd8+ t cells in-
creased,  it  was  still  lower  than  that  in  the  control
group (55.2% vs 83.6%, p < 0.05) (fig. 6).
However, expression of Cd127 on the surface of
Cd3+ Cd4+ t cells was not significantly different be-
tween the seven years of effective HaaRt, untreated
and control group (fig. 7).
dISCuSSIon
HIV-1 can, by infecting Cd4+ t cells, induce a pro-
gressive  decline  of  lymphocytes,  a  deficiency  in  im-
mune function and a variety of opportunistic infec-
tions. Cd8+ t cells are activated in the initial stage of
infection  as  the  main  defensive  barrier,  and  the  cy-
tolytic t lymphocyte response is soon induced to in-
hibit viral replication. Some transmembrane molecules
are highly expressed during the activation period, indi-
cating the activated state of cells [3, 4], for example,
Hla-dR and Cd38 molecules are indicators of t cell
activation. normally, these two molecules are seldom
expressed simultaneously on Cd4+ and Cd8+ t cells.
after infection, the Cd38 expression levels of t cells
are three to five times higher than normal, and they
correlate to disease progression [5]. 
In  the  present  study,  the  changes  in  Cd4+ and
Cd8+ t  cell  counts  were  investigated  during  seven
years of HaaRt. the study duration was partly cho-
sen because of external factors (exchange of staff be-
tween  Germany  and  China).  during  this  course  of
therapy, Cd4+ t cells increased and Cd8+ t cells de-
creased significantly (fig. 1). after the third year of
HaaRt, Cd4+ and Cd8+ t cell counts were main-
tained  at  stable  levels,  although  those  were  still  far
from the levels of the control group. this is in accor-
dance  with  observational  cohort  studies  where  a
plateau  is  reached  after  2-8  years  depending  on  the
baseline count [6]. It has been demonstrated that base-
line Cd4 count is a significant prognostic indicator for
HaaRt therapy. Some studies showed that patients
with the higher baseline Cd4 count at HaaRt initia-
tion  have  better  chance  to  restore  to  normal  Cd4
count [7-9]. In our study, we have done the correlate
analysis between baseline Cd4 and the recovery Cd4
counts after 1, 3, 5 and 7 years. the mean Cd4 recov-
ery was higher with high baseline Cd4 count, howev-
er, the related coefficient analysis was not very satis-
factory (P> 0.05). It may be caused by the small sam-
ple size.
Meanwhile,  the  fact  that  Cd8/Cd38+ and  Cd8/
HladR+ t cell counts in peripheral blood decreased
and, finally, fell to within the normal range, demon-
strated the decrease of abnormal immune activation.
However,  no  statistically  significant  reduction  in
Cd8/Cd38+ t cell counts was observed in the inef-
fective  HaaRt  patients  (fig.3).  although  Cd8/
HladR+ t cell counts gradually decreased, the de-
crease was less than in the effective HaaRt group
(fig. 4). thus, we conclude that long-term (at least 7
years) effective HaaRt could have an effect on im-
mune restauration in HIV-1-infected patients, and that
continued detection of Cd8/Cd38+ t cells is an opti-
mal way to quantify and explicate the immune activa-
tion  levels  in  HIV-1-infected  patients  undergoing
HaaRt.
Il-7 plays a crucial role in t cell homeostasis. this
cytokine is implicated in thymopoiesis, sustaining thy-
mocyte proliferation and survival. It also regulates pe-
ripheral naive t cell survival by inducing the produc-
tion of the anti-apoptotic molecule bcl-2 [10]. In a re-
cent  study,  subcutaneous  injection  of  rhIl-7  was
found to simultaneously increase Cd4+ and Cd8+ t
cell counts, particularly memory t cells [11]. Il-7 con-
centration in the peripheral blood of HIV-1-infected
patients was proven to be higher than that in healthy
people, and it was considered to accompany a decrease
in Cd4+t cells when the Il-7 production was induced
[10, 12]. on the basis of seven years investigation of
patients with effective HaaRt, the Il-7 in peripheral
blood decreased during antiretroviral therapy, but was
finally maintained at a stable level far above normal
levels. We speculate that HaaRt can inhibit HIV-1
reproduction, restore t cell subsets and Il-7 receptor
protein expression, and lower the negative feedback of
Il-7 to Cd4+ t as described by Chomont et al. [13].
the abnormal levels of Il-7 may be due to an incom-
plete recovery of the Il-7/Cd127 regulation mecha-
nisms after seven years of HaaRt. Chomont et al.
have also demonstrated that HaaRt can only partial-
ly downregulate the HIV reservoir [13], whereas Il-7-
induced  mitosis  of  transitional  memory  t  cells  can
lead to the persistence of the HIV reservoir [14].
the expression level and regulatory mechanism of
the Il-7Rʱ chain (Cd127) is positively correlated with
the  lifetime  of  t  cells  in  peripheral  blood  [15].
Cd127, as a specific surface marker of t cells, can be
used to clarify two mechanisms: the transformation of
effector  t  cells  to  memory  t  cells  and  the  mainte-
nance of memory t cells [16]. the expression levels
of Cd127 can be lowered by HIV-1-specific lympho-
cytes,  thereby  impairing  its  regulatory  function.
MacPherson et al. have found that downregulating the
expression level of Cd127 on Cd8+ t cells leads to a
proliferation of HIV [14]. However, the Cd127 ex-
pression in HIV-1-infected patients could be partially
recovered after antiviral therapy. furthermore, patients
with high expression levels of Cd127 enhanced Il-7
signals, stimulating the expression of bcl-2, and regu-
lating the survival and proliferation of t cells [17].
this study indicated that the expression of Cd127
on  the  surface  of  Cd3+ Cd8+ t  cells  in  untreated
HIV-1-infected  patients  was  lower  than  that  in  the
controls. after seven years of HaaRt, the Cd127 on
Cd3+ Cd8+ Cd45Ra+ t cells had increased to nor-
mal levels (fig. 6). We speculate that effector Cd4+
and Cd8+ t cells were activated due to the residual vi-
ral replication. the low Cd127 expression on Cd8+ t
cells could favour the apoptosis of effector Cd8+ t
cells, which abrogates the transformation of effector
Cd8+ t cells to memory t cells. therefore, HIV-1-
specific Cd8+ t cells could not survive longer. How-
ever, long-term HaaRt can inhibit the replication of
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of t cells, which could restore the quantity and capac-
ity of t cell subsets. there were no statistically signifi-
cant differences among the Cd127 expressions on the
surface  of  Cd3+ Cd4+ t  cells  in  the  effective
HaaRt group, the untreated group and the control
group. although similar results have already been re-
ported [13, 18], the specific mechanisms are not clear
and need further study. 
In  conclusion,  after  seven  years  of  effective
HaaRt, the quantity and capacity of t cell subsets
and Il-7 of HIV-1-infected patients were partially re-
stored, and the abnormal immune activation was sig-
nificantly reduced. However, seven years of HaaRt
could  not  achieve  complete  immune  reconstitution.
Continued investigation of Cd8/Cd38+ t cells may
help to monitor immune activation in HIV-1-infected
patients during long-term HaaRt. 
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